{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:03:10Z","timestamp":1789632190409,"version":"build-2803163510"},"reference-count":41,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15814","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T10:38:46Z","timestamp":1786531126000},"page":"1-8","source":"Crossref","is-referenced-by-count":0,"title":["Claudin\u201118.2: Molecular mechanisms to clinical translation in solid tumors (Review)"],"prefix":"10.3892","volume":"32","author":[{"given":"Minjie","family":"Zhang","sequence":"first","affiliation":[{"name":"Clinical Trials Center, Luanzhou People's Hospital, Tangshan, Hebei 063700, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Wu","sequence":"additional","affiliation":[{"name":"Clinical Trials Center, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tang","sequence":"additional","affiliation":[{"name":"Clinical Trials Center, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[{"name":"Clinical Trials Center, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Yan","sequence":"additional","affiliation":[{"name":"Clinical Trials Center, Luanzhou People's Hospital, Tangshan, Hebei 063700, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"key20260917101248_b1-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"7624","DOI":"10.1158\/1078-0432.CCR-08-1547","article-title":"Claudin 18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development","volume":"14","author":"Sahin","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20260917101248_b2-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"1132319","DOI":"10.3389\/fonc.2023.1132319","article-title":"Targeting CLDN18.2 in cancers of the gastrointestinal tract: New drugs and new indications","volume":"13","author":"Chen","year":"2023","journal-title":"Front Oncol"},{"key":"key20260917101248_b3-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"17588359231217967","DOI":"10.1177\/17588359231217967","article-title":"Zolbetuximab for claudin18.2-pos-itive gastric or gastroesophageal junction cancer","volume":"16","author":"Kubota","year":"2024","journal-title":"Ther Adv Med Oncol"},{"key":"key20260917101248_b4-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3892\/ol.2025.14886","article-title":"Claudin 18.2: An attractive marker in pancreatic ductal adenocarcinoma","volume":"29","author":"Valentini","year":"2025","journal-title":"Oncol Lett"},{"key":"key20260917101248_b5-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41571-024-00874-2","article-title":"Claudin 18.2 as a novel therapeutic target","volume":"21","author":"Nakayama","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"key20260917101248_b6-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1177\/10600280251342801","article-title":"Zolbetuximab-clzb: Targeting Claudin 18.2 in advanced gastric and gastroesophageal adenocarcinoma","volume":"59","author":"Gorwitz","year":"2025","journal-title":"Ann Pharmacother"},{"key":"key20260917101248_b7-ol-32-4-15814","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"key20260917101248_b8-ol-32-4-15814","article-title":"Zolbetuximab-clzb (Vyloy) [package insert]","author":"Pharma"},{"key":"key20260917101248_b9-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"OF8","DOI":"10.1158\/2159-8290.CD-NB2015-162","volume":"6","author":"Antibody Improves Survival in Gastric Cancer","year":"2016","journal-title":"Cancer Discov"},{"key":"key20260917101248_b10-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1038\/s41591-023-02465-7","article-title":"Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: The randomized, phase 3 GLOW trial","volume":"29","author":"Shah","year":"2023","journal-title":"Nat Med"},{"key":"key20260917101248_b11-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/S0140-6736(23)00620-7","article-title":"Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): A multicentre, randomised, double-blind, phase 3 trial","volume":"401","author":"Shitara","year":"2023","journal-title":"Lancet"},{"key":"key20260917101248_b12-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3390\/cancers16030679","article-title":"Claudin 18.2 as a new biomarker in gastric cancer-what should we know?","volume":"16","author":"Mathias-Machado","year":"2024","journal-title":"Cancers (Basel)"},{"key":"key20260917101248_b13-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1470-2045(24)00710-1","article-title":"Expanding therapeutic options targeting claudin-18.2","volume":"26","author":"Herbert","year":"2025","journal-title":"Lancet Oncol"},{"key":"key20260917101248_b14-ol-32-4-15814","first-page":"609","article-title":"FAST: A randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma. Ann","volume":"32","author":"Sahin","year":"2021","journal-title":"Oncol"},{"key":"key20260917101248_b15-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1056\/NEJMc2409512","article-title":"Zolbetuximab in gastric or gastroesophageal junction adenocarcinoma","volume":"391","author":"Shitara","year":"2024","journal-title":"N Engl J Med"},{"key":"key20260917101248_b16-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.4251\/wjgo.v14.i7.1252","article-title":"Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinoma","volume":"14","author":"Wang","year":"2022","journal-title":"World J Gastrointest Oncol"},{"key":"key20260917101248_b17-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1002\/ijc.31734","article-title":"CLDN18.1 attenuates malignancy and related signaling pathways of lung adenocarcinoma in vivo and in vitro","volume":"143","author":"Luo","year":"2018","journal-title":"Int J Cancer"},{"key":"key20260917101248_b18-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1097\/PAS.0000000000002464","article-title":"Claudin 18.2 and other therapeutic biomarkers in gastric and gastroesophageal junction adenocarcinomas","volume":"49","author":"Liu","year":"2025","journal-title":"Am J Surg Pathol"},{"key":"key20260917101248_b19-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3390\/jpm11111095","article-title":"Association of CLDN18 protein expression with clinicopathological features and prognosis in advanced gastric and gastroesophageal junction adenocarcinomas","volume":"11","author":"Pellino","year":"2021","journal-title":"J Pers Med"},{"key":"key20260917101248_b20-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13045-017-0473-4","article-title":"Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer","volume":"10","author":"Singh","year":"2017","journal-title":"J Hematol Oncol"},{"key":"key20260917101248_b21-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jcmgh.2020.10.005","article-title":"Claudin-18 loss alters transcellular chloride flux but not tight junction ion selectivity in gastric epithelial cells","volume":"11","author":"Caron","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"key20260917101248_b22-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1053\/j.gastro.2011.10.040","article-title":"Deficiency of claudin-18 causes paracellular H+ leakage, up-regulation of interleukin-1\u03b2, and atrophic gastritis in mice","volume":"142","author":"Hayashi","year":"2012","journal-title":"Gastroenterology"},{"key":"key20260917101248_b23-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1038\/onc.2011.43","article-title":"Claudin-2 expression increases tumorigenicity of colon cancer cells: Role of epidermal growth factor receptor activation","volume":"30","author":"Dhawan","year":"2011","journal-title":"Oncogene"},{"key":"key20260917101248_b24-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1369\/0022155411420569","article-title":"Claudin-18 is an early-stage marker of pancreatic carcinogenesis","volume":"59","author":"Tanaka","year":"2011","journal-title":"J Histochem Cytochem"},{"key":"key20260917101248_b25-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12964-023-01406-8","article-title":"Claudin-18.2 mediated interaction of gastric cancer cells and cancer-associated fibroblasts drives tumor progression","volume":"22","author":"Liu","year":"2024","journal-title":"Cell Commun Signal"},{"key":"key20260917101248_b26-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1053\/j.gastro.2018.08.041","article-title":"Loss of tight junction protein claudin 18 promotes progressive neoplasia development in mouse stomach","volume":"155","author":"Hagen","year":"2018","journal-title":"Gastroenterology"},{"key":"key20260917101248_b27-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"G336","DOI":"10.1152\/ajpgi.00328.2007","article-title":"Transcriptional activation of the human claudin-18 gene promoter through two AP-1 motifs in PMA-stimulated MKN45 gastric cancer cells","volume":"294","author":"Yano","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"key20260917101248_b28-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1002\/jcb.23095","article-title":"Transcriptional regulation of claudin-18 via specific protein kinase C signaling pathways and modification of DNA methylation in human pancreatic cancer cells","volume":"112","author":"Ito","year":"2011","journal-title":"J Cell Biochem"},{"key":"key20260917101248_b29-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"10660","DOI":"10.1074\/jbc.M110.208041","article-title":"Neuregulin-1-human epidermal receptor-2 signaling is a central regulator of pulmonary epithelial permeability and acute lung injury","volume":"286","author":"Finigan","year":"2011","journal-title":"J Biol Chem"},{"key":"key20260917101248_b30-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"7380","DOI":"10.1128\/MCB.21.21.7380-7390.2001","article-title":"Claudin-18, a novel downstream target gene for the T\/EBP\/NKX2.1 homeodomain transcription factor, encodes lung- and stomach-specific isoforms through alternative splicing","volume":"21","author":"Niimi","year":"2001","journal-title":"Mol Cell Biol"},{"key":"key20260917101248_b31-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1007\/s10620-014-3107-5","article-title":"miR-1303 targets claudin-18 gene to modulate proliferation and invasion of gastric cancer cells","volume":"59","author":"Zhang","year":"2014","journal-title":"Dig Dis Sci"},{"key":"key20260917101248_b32-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1053\/j.gastro.2011.10.040","article-title":"Deficiency of claudin-18 causes paracellular H+ leakage, up-regulation of interleukin-1\u03b2, and atrophic gastritis in mice","volume":"142","author":"Hayashi","year":"2012","journal-title":"Gastroenterology"},{"key":"key20260917101248_b33-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00428-011-1092-z","article-title":"Claudin-18 in biliary neoplasms. Its significance in the classification of intrahepatic cholangiocarcinoma","volume":"459","author":"Shinozaki","year":"2011","journal-title":"Virchows Arch"},{"key":"key20260917101248_b34-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"e012683","DOI":"10.1136\/jitc-2025-012683","article-title":"Dynamic modulation of claudin 18.2 expression and remodeling of the tumor microenvironment in gastric cancer during chemo-immunotherapy","volume":"13","author":"Lim","year":"2025","journal-title":"J Immunother Cancer"},{"key":"key20260917101248_b35-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"100589","DOI":"10.1016\/j.modpat.2024.100589","article-title":"Claudin-18.2 Immunohistochemical evaluation in gastric and gastroesophageal junction adenocarcinomas to direct targeted therapy: A practical approach","volume":"37","author":"Fassan","year":"2024","journal-title":"Mod Pathol"},{"key":"key20260917101248_b36-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"20047","DOI":"10.1038\/s41598-023-47178-6","article-title":"Clinicopathologic features and prognostic value of claudin 18.2 overexpression in patients with resectable gastric cancer","volume":"13","author":"Kim","year":"2023","journal-title":"Sci Rep"},{"key":"key20260917101248_b37-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.3390\/cancers15092639","article-title":"Updated epidemiology of gastric cancer in asia: Decreased incidence but still a big challenge","volume":"15","author":"Shin","year":"2023","journal-title":"Cancers (Basel)"},{"key":"key20260917101248_b38-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"S934","DOI":"10.1016\/j.annonc.2024.08.1595","article-title":"1532TiP Zolbetuximab with gemcitabine + nab-paclitaxel (GN) in first-line treatment of Claudin 18.2\u2013positive metastatic pancreatic cancer (mPC): Phase II, open-label, randomized study","volume":"35","author":"Park","year":"2024","journal-title":"Ann Oncol"},{"key":"key20260917101248_b39-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1515\/cclm-2024-0986","article-title":"Circulating tumor DNA measurement: A new pillar of medical oncology?","volume":"62","author":"Melichar","year":"2024","journal-title":"Clin Chem Lab Med"},{"key":"key20260917101248_b40-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"217362","DOI":"10.1016\/j.canlet.2024.217362","article-title":"Emerging targets in gastric and pancreatic cancer: Focus on claudin 18.2","volume":"611","author":"Tojjari","year":"2024","journal-title":"Cancer Lett"},{"key":"key20260917101248_b41-ol-32-4-15814","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.bulcan.2024.10.006","article-title":"Claudine 18.2: A new therapeutic target in digestive cancers","volume":"111","author":"Blondet","year":"2024","journal-title":"Bull Cancer"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:13:32Z","timestamp":1789629212000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8,12]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15814","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]}}}